Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Suvan Lifesciences
Hyderabad, Telangana, India
- Ownership
- Private
- Employees
- ~1200
- Development stage
- Other
01
Overview
Suven Life Sciences is a clinical-stage biopharmaceutical company focused on the discovery and development of New Chemical Entities (NCEs) for Central Nervous System (CNS) disorders. Its lead candidate, Masupirdine (SUVN-502), is currently in a global Phase 3 trial for agitation in patients with Alzheimer's disease. The company's pipeline also includes Ropanicant (Phase 2b for Major Depressive Disorder) and Samelisant (Phase 2 for Narcolepsy).
- Therapeutic areas
- PsychiatryNeurologyGastroenterology
- Modalities
- Small molecule
- Industry
- Biotech
02
Partnerships
Prexa PharmaceuticalsReviva Pharmaceuticals
Beyond the preview
Go deeper on Suvan Lifesciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Suvan Lifesciences.